Business Context and Reporting Period
This Form 8-K was filed by OneMedNet Corporation (ONMD) on October 16, 2024. The filing addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the Company's compliance with continued listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the status of the Company's stock listing.
Material Changes
- Listing Deficiency: The Company received notification that its Common Stock failed to meet the minimum bid price requirement of $1.00 per share for 30 consecutive business days prior to October 16, 2024.
- Compliance Period: The Company has been granted a 180-calendar-day compliance period, ending on April 14, 2025, to regain compliance.
- Current Status: The notification is a deficiency notice only; it does not result in immediate delisting or affect current trading on Nasdaq.
Outlook, Risks, and Management Commentary
- Compliance Path: To regain compliance, the stock must maintain a closing bid price of at least $1.00 for 10 consecutive business days during the compliance period.
- Secondary Compliance Option: If the Company fails to meet the bid price requirement by April 14, 2025, it may be eligible for an additional 180-day period if it meets other listing standards (excluding bid price) and notifies Nasdaq of its intent to cure, potentially via a reverse stock split.
- Risks: Management states there can be no assurance that the Company will be able to regain or maintain compliance. Failure to cure the deficiency could lead to delisting, subject to appeal.
- Management Action: The Company intends to actively monitor the bid price and evaluate available options to resolve the deficiency.
Investor Verification Checklist
- Verify the current trading price of ONMD relative to the $1.00 minimum bid threshold.
- Monitor for any announcements regarding a reverse stock split prior to the April 14, 2025 deadline.
- Check for any subsequent correspondence from Nasdaq regarding the Company's eligibility for a second compliance period.
- Review the Company's market value of publicly held shares to ensure it meets other Nasdaq Capital Market initial listing standards.